Falk Catalyst Research Award Program
Seed funding for early-stage, high-risk translational biomedical research targeting disease biomarkers, therapeutic targets, or new interventions with near-term clinical potential.
Funder: Health Resources in Action
Due Dates (Anticipated): June 2027 (Full application deadline, projected; submit by 2:00 PM Eastern Time)
Funding Amounts: Up to $350,000 over 1–2 years (including max 10% indirect costs) per award
Summary: Seed funding for high-risk, high-reward translational biomedical research projects with near-term clinical potential.
Key Information: Only invited institutions may apply; each may nominate up to 2 projects per cycle.
Description
The program provides seed funding to support early-stage, high-risk translational research projects that address critical scientific or therapeutic barriers and have the potential to move rapidly into clinical practice. Supported research includes the identification of disease biomarkers, therapeutic targets, and the development of agents or devices to disrupt or prevent disease processes. The award aims to lay the groundwork for future applications to the larger Transformational Award, which can provide additional support for projects showing strong progress.
